A Nanocarrier Skin-Targeted Drug Delivery System using an Ascorbic Acid Derivative
Yutaka Inoue(The University of Osaka), Ikuo Kanamoto(Josai University), Isamu Murata(Josai University), Mitsue Hibino(Hokkaido University)
Cited by 39
Related Papers
Power of mitochondrial drug delivery systems to produce innovative nanomedicines
|Advanced Drug Delivery Reviews|2020|123
Challenges in Promoting Mitochondrial Transplantation Therapy
|International Journal of Molecular Sciences|2020|106
Severe corneal dystrophy phenotype caused by homozygous R124H keratoepithelin mutations.
|PubMed|1998|86
Therapeutic Strategies for Regulating Mitochondrial Oxidative Stress
|Biomolecules|2020|73